Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Mar;59(3):539-41.
doi: 10.1161/HYPERTENSIONAHA.111.188714. Epub 2012 Jan 23.

Angiotensin II infusion model of hypertension: is there an important sympathetic component?

Editorial

Angiotensin II infusion model of hypertension: is there an important sympathetic component?

Thomas E Lohmeier. Hypertension. 2012 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
ANG II has multiple acute and chronic effects to increase blood pressure. However, chronic ANG II hypertension is dependent on the sodium retaining effects of ANG II. Thus, one way ANG II can cause hypertension is by having sustained effects to increase RSNA. In the ANG II infusion model of hypertension, the temporal changes in central sympathetic outflow reflect the balance between the direct excitatory actions of ANG II on the brain and the indirect effects of pressure-mediated baroreflex activation to inhibit sympathetic outflow. Despite the possibility that ANG II may chronically increase RSNA, this action appears to play a minor role in the maintenance of ANG II hypertension. The effects of ANG II that are dominant in mediating chronic hypertension are indicated by the bold arrows in the Figure. ANG II indicates angiotensin II; RSNA, renal sympathetic nerve activity; TPR, total peripheral resistance.

Comment on

Similar articles

Cited by

References

    1. Guild SJ, McBryde FD, Malpas SC, Barrett CJ. High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity; a direct telemetric study. Hypertension. in press, current issue of Hypertension. - PubMed
    1. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963–985. - PubMed
    1. Carroll RG, Lohmeier TE, Brown AJ. Chronic angiotensin II infusion decreases renal norepinephrine overflow in the conscious dog. Hypertension. 1987;6:675–681. - PubMed
    1. Simplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment resistant hypertension (The Symplicity HTN-2 Trial): a randomized controlled trial. Lancet. 2011;376:1903–1909. - PubMed
    1. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos Pivotal trial. J Am Coll Cardiol. 2011;58:765–773. - PubMed